Lung Kee Group Holdings Limited

As of June 30, 2026, Lung Kee Group Holdings Limited carries a market capitalization of 900.29M, placing it among publicly traded companies globally. Its enterprise value stands at 253.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Lung Kee Group Holdings Limited has 634.01M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Lung Kee Group Holdings Limited maintains a current ratio of 6.38, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Lung Kee Group Holdings Limited's stock has declined approximately 26.74% over the past 52 weeks. The 50-day moving average sits at 1.43, while the 200-day moving average is 1.55.

As of June 30, 2026, Lung Kee Group Holdings Limited holds 649.71M in cash and equivalents against 2.79M in total debt, resulting in a net debt position of -649.71M. Total book value stands at 1.51B, with working capital of 914.53M providing operational flexibility.

Lung Kee Group Holdings Limited's most recent stock split took place on April 26, 2004 with a 4:5 split ratio.